The AstraZeneca-Oxford vaccine (AZD1222) is a chimpanzee adenovirus-vectored vaccine. This means that the company took a virus that normally infects chimpanzees, and genetically modified it.
Adenovirus-vectored vaccines have been in development for a long time, in particular against malaria, HIV and Ebola. But no adenovirus vaccine has ever before been approved for use on humans in the USA. Some adenovirus vaccines in past trials have been simply ineffective, while others have been attacked by the body’s immune system (human adenoviruses can cause the common cold, so some people already have antibodies to these viruses).
AstraZeneca’s vaccine can be transported and stored at the same temperatures you might find in a normal refrigerator – between about 36° and 46° Fahrenheit for as long as six months.
01.04.2021 Germany has reported 31 cases of blood clots in the brain from AstraZeneca COVID-19 vaccine. Use of AstraZeneca covid-19 vaccine has already been suspended in many European countries due to its adverse side effects.
16.03.2021 More than 20 countries have either suspended or said they will delay Oxford-AstraZeneca vaccinations based on reports of deaths or injuries — in most cases related to blood clots — in healthy people who received the vaccine.
Prosecutors in Northern Italy announced Monday they had seized a batch of 393,600 shots of the AstraZeneca COVID vaccine following the death of a 57-year-old man hours after he was vaccinated.. Read More HERE >>
11.03.2021 – Europe. 8 countries including Italy, Latvia, Luxembourg, Lithuania, Estonia, Denmark, Norway and Iceland have decided to stop using the AstraZeneca COVID-19 vaccine due to serious blood clot incidents. Read more >>
AstraZeneca pauses its COVID-19 vaccine safety trial after a participant develops Neurological Symptoms. Apparently, the woman’s symptoms were consistent with transverse myelitis (TM). TM is a neurological disorder characterized by inflammation of the spinal cord, a major element of the central nervous system. Read more >>